70
Participants
Start Date
December 22, 2021
Primary Completion Date
March 31, 2029
Study Completion Date
March 31, 2029
ION582
ION582 will be administered by IT injection.
RECRUITING
University of North Carolina at Chapel Hill School of Medicine, Carrboro
RECRUITING
Azienda Ospedaliera Universitaria Pisana, Pisa
RECRUITING
Rush University Medical Center, Chicago
ACTIVE_NOT_RECRUITING
Necker-Enfants Malades Hospital, Paris
ACTIVE_NOT_RECRUITING
Texas Children's Hospital, Houston
RECRUITING
Colorado Children's Hospital Research Institute, Aurora
ACTIVE_NOT_RECRUITING
Rady Children's Hospital, San Diego
RECRUITING
Sheba Medical Center, Ramat Gan
RECRUITING
Boston Children's Hospital, Boston
ACTIVE_NOT_RECRUITING
Sydney Children's Hospital, Kids Cancer Centre, Randwick
ACTIVE_NOT_RECRUITING
STRONG Group University of Oxford, Oxford
Lead Sponsor
Ionis Pharmaceuticals, Inc.
INDUSTRY